TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23062389

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol 320 mg/d
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study: 21349587

Group type: EXPERIMENTAL
Intervention: Elevated depressive symptoms (DS)
Number of subjects: 1372

Group type: COMPARATOR
Intervention: No elevated depressive symptoms (non-depressed women)
Number of subjects: 1372
Study: 19156009

Group type: EXPERIMENTAL
Intervention: PureVision multifocal contact lens
Number of subjects: 20

Group type: COMPARATOR
Intervention: Monovision with PureVision single vision lenses
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High addition multifocal lens
Number of subjects: 20
Study: 17365897

Group type: EXPERIMENTAL
Intervention: ICD implantation
Number of subjects: 49
Study: 15110882

Group type: EXPERIMENTAL
Intervention: Droperidol (2.5 mg d.i.v. twice daily for 5 days) combined with granisetron (3 mg d.i.v. on the first day) and dexamethasone (16 mg d.i.v. on the first day, 8 mg d.i.v. on days 2, 3, and 4)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo combined with granisetron (3 mg d.i.v. on the first day) and dexamethasone (16 mg d.i.v. on the first day, 8 mg d.i.v. on days 2, 3, and 4)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Droperidol (2.5 mg d.i.v. twice daily for 5 days)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 11673125

Group type: EXPERIMENTAL
Intervention: Copper sulfate (soluble copper)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Copper oxide (insoluble copper)
Number of subjects: 45
Study: 10164160

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8239224

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine, 400 mg daily
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 3553336

Group type: EXPERIMENTAL
Intervention: Antibody-affinity-purified tetanus toxoid vaccine
Number of subjects: 205

Group type: COMPARATOR
Intervention: Standard (commercial) tetanus toxoid vaccine
Number of subjects: 205
Study: 30232110

Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACEs)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Connectedness and social support
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Spiritual activities
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Diabetes-specific support
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Social support and diabetes-specific social support
Number of subjects: 192
Study: 26691410

Group type: EXPERIMENTAL
Intervention: 75 g glucose
Number of subjects: 17

Group type: COMPARATOR
Intervention: Isovolumic placebo (saccharin-flavored) drink
Number of subjects: 17
Study: 24144308

Group type: EXPERIMENTAL
Intervention: MPR-R (melphalan-prednisone-lenalidomide followed by lenalidomide maintenance)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MPR-R
Number of subjects: 0

Group type: COMPARATOR
Intervention: MP (melphalan-prednisone)
Number of subjects: 0
Study: 22363492

Group type: EXPERIMENTAL
Intervention: Psilocybin administration
Number of subjects: 261
Study: 19819634

Group type: EXPERIMENTAL
Intervention: 2 mg kg(‐1) ketamine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1 mg kg(‐1) tramadol + 30 min later 1 microg kg(‐1) dexmedetomidine + 2 mg kg(‐1) ketamine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1 mg kg(‐1) tramadol + 30 min later 0.05 mg kg(‐1) midazolam + 2 mg kg(‐1) ketamine
Number of subjects: 24
Study: 17485968

Group type: EXPERIMENTAL
Intervention: Participatory decision making (PDM) style
Number of subjects: 554
Study: 15900306

Group type: EXPERIMENTAL
Intervention: Dietary portfolio (high in plant sterols, soy protein, viscous fibers, and almonds)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Statin (20 mg lovastatin)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (very low-saturated fat diet)
Number of subjects: 34
Study: 12164888

Group type: EXPERIMENTAL
Intervention: Blood volume tracking (BVT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional hemodialysis
Number of subjects: 36
Study: 7698386

Group type: EXPERIMENTAL
Intervention: Dilapan-gemeprost
Number of subjects: 153

Group type: COMPARATOR
Intervention: Rivanol-oxytocin (immediate)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Rivanol-oxytocin (16-h)
Number of subjects: 153
Study: 2527856

Group type: EXPERIMENTAL
Intervention: Cortisone and local anaesthetic injected into two facet joints
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Cortisone and local anaesthetic injected around two facet joints
Number of subjects: 109

Group type: COMPARATOR
Intervention: Physiological saline injected into two facet joints
Number of subjects: 109
Study: 363629

Group type: EXPERIMENTAL
Intervention: Mazindol (two preparations)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physician therapists
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonphysician therapists
Number of subjects: 60
Study: 31255591

Group type: EXPERIMENTAL
Intervention: Biannual mass drug administration (MDA) with praziquantel alone (arm 1)
Number of subjects: 8278

Group type: EXPERIMENTAL
Intervention: Biannual mass drug administration (MDA) with snail control (arm 2)
Number of subjects: 8278

Group type: EXPERIMENTAL
Intervention: Biannual mass drug administration (MDA) with behaviour change activities (arm 3)
Number of subjects: 8278
Study: 28865830

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacilli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard milk
Number of subjects: 0
Study: 24938711

Group type: EXPERIMENTAL
Intervention: Vitamin B group (800 µg/day of folate, 10 mg of vitamin B6, 25 µg of vitamin B12)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Vitamin B group
Number of subjects: 104
Study: 23593636

Group type: EXPERIMENTAL
Intervention: 20% citric acid + 2% CHX with rotary instrumentation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 5% NaOCl + 17% EDTA with rotary instrumentation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 5% NaOCl + 17% EDTA with RealSeal
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 5% NaOCl + 17% EDTA with EndoREZ
Number of subjects: 48
Study: 21768610

Group type: EXPERIMENTAL
Intervention: Switch to aripiprazole
Number of subjects: 215

Group type: COMPARATOR
Intervention: Stay on current medication (olanzapine, quetiapine, or risperidone)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Stay on current medication
Number of subjects: 215
Study: 18937957

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Multi-micronutrient supplementation
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study: 17076978

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 94

Group type: COMPARATOR
Intervention: Travoprost 0.004%
Number of subjects: 94
Study: 15566075

Group type: EXPERIMENTAL
Intervention: Magnetocardiogram (MCG)
Number of subjects: 86

Group type: COMPARATOR
Intervention: 12-lead ECG
Number of subjects: 86
Study: 11779098

Group type: EXPERIMENTAL
Intervention: r‐HuEPO (750 U/kg a week) administered for 6 weeks starting on the 10th day of life
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no r‐HuEPO treatment)
Number of subjects: 40
Study: 9929207

Group type: EXPERIMENTAL
Intervention: Automated coding
Number of subjects: 38

Group type: COMPARATOR
Intervention: Manual coding
Number of subjects: 38
Study: 7995329

Group type: EXPERIMENTAL
Intervention: Tenoxicam with Diazoxide
Number of subjects: 10

Group type: COMPARATOR
Intervention: Diazoxide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tenoxicam
Number of subjects: 10
Study: 2661768

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine plus azathioprine plus prednisolone (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cyclosporine and azathioprine alone (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Maintenance steroids (group C)
Number of subjects: 60
Study: 29865884

Group type: EXPERIMENTAL
Intervention: Self-control resources depleted
Number of subjects: 32

Group type: COMPARATOR
Intervention: Self-control resources not depleted
Number of subjects: 32
Study: 30188953

Group type: EXPERIMENTAL
Intervention: Short-acting muscarinic antagonists (SAMAs)
Number of subjects: 12774

Group type: EXPERIMENTAL
Intervention: Short-acting beta-agonists (SABAs)
Number of subjects: 12774

Group type: EXPERIMENTAL
Intervention: Statin
Number of subjects: 12774

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 12774

Group type: EXPERIMENTAL
Intervention: COPD cohort
Number of subjects: 12774

Group type: COMPARATOR
Intervention: Control cohort
Number of subjects: 12774
Study: 29145792

Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention (two sessions delivered at home by local community health workers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 0
Study: 25970665

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Gluten-containing diet (GCD)
Number of subjects: 13
Study: 23890536

Group type: EXPERIMENTAL
Intervention: Video self-instruction (VSI) on CPR and AEDs
Number of subjects: 1616
Study: 21748765

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 400 mg three times a day
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 19916995

Group type: EXPERIMENTAL
Intervention: Voriconazole (400 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 16534710

Group type: EXPERIMENTAL
Intervention: Occupational Therapy (OT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (C) - Conventional care
Number of subjects: 100
Study: 12766657

Group type: EXPERIMENTAL
Intervention: Epidural lidocaine and fentanyl before incision (group 1)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Epidural saline before incision and epidural lidocaine and fentanyl 40 min after incision (group 2)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Sham epidural control (group 3)
Number of subjects: 141
Study: 10966142

Group type: EXPERIMENTAL
Intervention: Short opponens splint
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Long opponens splint
Number of subjects: 26
Study: 9314127

Group type: EXPERIMENTAL
Intervention: Propranolol (0.15 mg/kg i.v., n = 60)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Propranolol (0.15 mg/kg i.v.)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 80
Study: 7880947

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 3378554

Group type: EXPERIMENTAL
Intervention: Suxamethonium administration with i.v. induction and pre-treatment with alcuronium 0.04 mg kg‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Suxamethonium administration with i.v. induction without pre-treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Suxamethonium administration with inhalation induction and pre-treatment with alcuronium 0.04 mg kg‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Suxamethonium administration with inhalation induction without pre-treatment
Number of subjects: 40
Study: 29582734

Group type: EXPERIMENTAL
Intervention: Norovirus vaccine interest survey
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: Higher education households
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: Lower WTP households
Number of subjects: 627
Study: 27538743

Group type: EXPERIMENTAL
Intervention: Glucobrassicin doses ranging from 25 to 500 μmol, once daily for 2 consecutive days
Number of subjects: 45
Study: 25614139

Group type: EXPERIMENTAL
Intervention: Families Improving Together (FIT) intervention
Number of subjects: 0
Study: 22971593

Group type: EXPERIMENTAL
Intervention: On-site rapid testing with information only
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: On-site rapid testing with risk-reduction counseling
Number of subjects: 12

Group type: COMPARATOR
Intervention: Off-site testing referral
Number of subjects: 12
Study: 20876596

Group type: EXPERIMENTAL
Intervention: 0.2 ml of sucrose 24% given by mouth using a syringe and a soother
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.2 ml of sterile water given by mouth using a syringe and a soother (Control)
Number of subjects: 40
Study: 18376000

Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Simvastatin plus Ezetimibe (10 mg)
Number of subjects: 720
Study: 16772456

Group type: EXPERIMENTAL
Intervention: High dry bean intake (highest quartile of change in intake)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (lowest quartile of dry bean intake)
Number of subjects: 0
Study: 12691335

Group type: EXPERIMENTAL
Intervention: TENS40 (40 minutes)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: TENS60 (60 minutes)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: TENS20 (20 minutes)
Number of subjects: 38

Group type: COMPARATOR
Intervention: TENS(PL) (60 minutes placebo)
Number of subjects: 38
Study: 11053614

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (2 g daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9120226

Group type: EXPERIMENTAL
Intervention: Gabapentin monotherapy (9.7 through 19.1 mg/kg/day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Gabapentin monotherapy
Number of subjects: 33
Study: 1552457

Group type: EXPERIMENTAL
Intervention: PT-01 (controlled-release insert containing ofloxacin) applied once a week for 4 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control insert without any antibacterial agent
Number of subjects: 46
Study: 3537822

Group type: EXPERIMENTAL
Intervention: Chymodiactin
Number of subjects: 1606

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1606
Study: 28927866

Group type: EXPERIMENTAL
Intervention: Metacognitive training for BPD
Number of subjects: 74

Group type: COMPARATOR
Intervention: Progressive muscle relaxation training
Number of subjects: 74
Study: 27113598

Group type: EXPERIMENTAL
Intervention: Metronome cueing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flashing light cueing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Optic flow cueing
Number of subjects: 12

Group type: COMPARATOR
Intervention: No-cue (control condition)
Number of subjects: 12
Study: 24690207

Group type: EXPERIMENTAL
Intervention: Tissue glue (Tisseel)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Staples
Number of subjects: 82
Study: 24447354

Group type: EXPERIMENTAL
Intervention: Low molecular heparin 4 kU once a day for 7 days
Number of subjects: 63

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 63
Study: 20643390

Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose oral contraceptive (OC)
Number of subjects: 0
Study: 18761479

Group type: EXPERIMENTAL
Intervention: Patching
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Perceptual learning
Number of subjects: 53
Study: 15919453

Group type: EXPERIMENTAL
Intervention: CNI withdrawal (cyclosporine or tacrolimus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CNI continuation (cyclosporine or tacrolimus)
Number of subjects: 0
Study: 12949361

Group type: EXPERIMENTAL
Intervention: Very low carbohydrate diet (<10% carbohydrate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low fat diet (<30% fat)
Number of subjects: 10
Study: 10930115

Group type: EXPERIMENTAL
Intervention: IBR/CT group
Number of subjects: 52

Group type: COMPARATOR
Intervention: CT group
Number of subjects: 52
Study: 8889437

Group type: EXPERIMENTAL
Intervention: Butter diet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tallow diet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Corn oil diet
Number of subjects: 8

Group type: COMPARATOR
Intervention: All diets
Number of subjects: 8
Study: 1739722

Group type: EXPERIMENTAL
Intervention: Polymacon intraocular lens
Number of subjects: 290

Group type: COMPARATOR
Intervention: PMMA intraocular lens
Number of subjects: 290
Study: 6415744

Group type: EXPERIMENTAL
Intervention: 10 mg naloxone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 6
Study: 30857514

Group type: EXPERIMENTAL
Intervention: Continuous infusion of β-lactam antibiotics (piperacillin-tazobactam or meropenem)
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Intermittent infusion of β-lactam antibiotics (piperacillin-tazobactam or meropenem)
Number of subjects: 7000
Study: 29437202

Group type: EXPERIMENTAL
Intervention: Exercise intervention (primarily brisk walking)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 95
Study: 26930568

Group type: EXPERIMENTAL
Intervention: High spinal anesthesia
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (general anesthesia only)
Number of subjects: 14
Study: 25203332

Group type: EXPERIMENTAL
Intervention: IV ketamine 0.5 mg/kg (Group K)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: IV tramadol 0.5 mg/kg (Group T)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Normal saline (Group P)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 150
Study: 22753773

Group type: COMPARATOR
Intervention: Tocilizumab 8 mg/kg
Number of subjects: 489

Group type: COMPARATOR
Intervention: Tocilizumab 4 mg/kg
Number of subjects: 489

Group type: COMPARATOR
Intervention: Tocilizumab (both doses)
Number of subjects: 489
Study: 20929380

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation intervention (90-minute session per week for 7 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Education class based on Powerful Tools for Caregivers (90-minute session per week for 7 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Respite-only group (same duration of respite care as active interventions)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation intervention
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Education class based on Powerful Tools for Caregivers
Number of subjects: 31
Study: 17662102

Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (180 microg/week) for 60 wk
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (180 microg/week) for 12 wk followed by 48 wk of peginterferon alfa-2a plus lamivudine
Number of subjects: 13
Study: 15876830

Group type: EXPERIMENTAL
Intervention: High-flux hemodialysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose hemodialysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional three times per week hemodialysis
Number of subjects: 0
Study: 12037147

Group type: EXPERIMENTAL
Intervention: Low-dose subcutaneous ultralente insulin, administered twice daily for a total dose of 0.25 unit per kilogram of body weight per day, plus annual four-day continuous intravenous infusions of insulin.
Number of subjects: 339

Group type: COMPARATOR
Intervention: Close observation (Control group)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Low-dose subcutaneous ultralente insulin
Number of subjects: 339
Study: 10215708

Group type: EXPERIMENTAL
Intervention: 1% ropivacaine with hyaluronidase
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.75% bupivacaine with hyaluronidase
Number of subjects: 100
Study: 7890058

Group type: EXPERIMENTAL
Intervention: 100 micrograms SC GRF on cycle days 2 to 11
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control cycle (no treatment)
Number of subjects: 7
Study: 2213040

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 60
Study: 444954

Group type: EXPERIMENTAL
Intervention: Two-drug regimen (vinblastine and procarbazine)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Four-drug regimen (MVPP)
Number of subjects: 108
Study: 29577789

Group type: EXPERIMENTAL
Intervention: Double transverse compression suture at the lower uterine segment plus intrauterine inflated Foley's catheter Balloon (H&N variation sandwich)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Stepwise uterine devascularization
Number of subjects: 106
Study: 28283694

Group type: EXPERIMENTAL
Intervention: Haptic anchors
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rigid railing
Number of subjects: 28

Group type: COMPARATOR
Intervention: Both haptic tools (rigid railing and haptic anchors)
Number of subjects: 28
Study: 26188373

Group type: EXPERIMENTAL
Intervention: PST with weekly support (n = 106)
Number of subjects: 537

Group type: COMPARATOR
Intervention: PST without support (n = 107)
Number of subjects: 537

Group type: COMPARATOR
Intervention: PST with support on request (n = 108)
Number of subjects: 537

Group type: COMPARATOR
Intervention: No Internet‐based intervention but non‐specific chat or email (n = 110)
Number of subjects: 537

Group type: COMPARATOR
Intervention: Waitlist control (WLC; n = 106)
Number of subjects: 537
Study: 23485413

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (1200 IU/d)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 20932687

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy (CRT)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Preoperative radiotherapy (RT)
Number of subjects: 207
Study: 19154656

Group type: COMPARATOR
Intervention: Placebo/Placebo
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo/Ketamine (0.3 mg/kg i.v.)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Haloperidol (2 mg)/Ketamine (0.3 mg/kg i.v.)
Number of subjects: 18
Study: 18589555

Group type: EXPERIMENTAL
Intervention: Epoetin zeta (10,000 IU, intravenous bolus injection)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Epoetin alfa (10,000 IU, intravenous bolus injection)
Number of subjects: 24
Study: 15760929

Group type: EXPERIMENTAL
Intervention: 120 mg IM depomedrone
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 12082319

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 60
Study: 9498533

Group type: EXPERIMENTAL
Intervention: Intravenous aspirin
Number of subjects: 19